Safety Evaluation of Prismocitrate 18 in Patients Receiving CRRT
מצבים רפואיים
Regional Citrate Anticoagulation (RCA) · Continuous Renal Replacement Therapy (CRRT) · Acute Kidney Injury (AKI)
סיכום בשפה פשוטהבעזרת בינה מלאכותית
הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.
מיקומים
University of Alabama at Birmingham/UAB, Birmingham, Alabama, United States
Contact: Principal Investigator (Eric Judd, MD)University of Southern California (USC) / Keck Hospital, Los Angeles, California, United States
Contact: Principal Investigator (Fadi Tohme, MD)University of California Los Angeles, Los Angeles, California, United States
University of Miami, Miami, Florida, United States
Contact: Principal Investigator (Juan Duque, MD)Emory University, Atlanta, Georgia, United States
Contact: Principal Investigator (Michael J Connor Jr., MD)University of Michigan, Ann Arbor, Michigan, United States
Contact: Principal Investigator (Lenar Yessayan, MD)Bon Secours Mercy Health-Springfield Regional Medical Center, Springfield, Ohio, United States
Geisinger Medical Center, Danville, Pennsylvania, United States
Penn State Hershey Medical Center, Hershey, Pennsylvania, United States
VA Pittsburgh Healthcare System, Pittsburgh, Pennsylvania, United States
Medical University of South Carolina (MUSC), Charleston, South Carolina, United States
Contact: Principal Investigator (Blaithin McMahon, MD)Lt. Col. Luke Weathers, Jr. VA Medical Center, Memphis, Tennessee, United States
Contact: Principal Investigator (Geeta Gyamlani, MD)Methodist Dallas Medical Center, Dallas, Texas, United States
Contact: Principal Investigator (Roberto Collazo-Maldonado, MD)Gamma Medical Research, Inc / McAllen Medical Center, McAllen, Texas, United States